Method for preparing supported palladium catalyst from carbonate solution
A supported palladium and carbonate technology, applied in chemical instruments and methods, physical/chemical process catalysts, chemical recovery, etc., can solve the problems of long catalyst preparation time, long process, poor reproducibility, etc., and save experiments The effect of cost, simple process and short preparation time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Pipette 0.5ml PdCl 2 solution, add 19.5ml of ethylene glycol, mix evenly to form a light yellow solution, and put it into No. 1 syringe; put dodecane into No. 2 syringe as the carrier phase. The flow rate of the solution in No. 1 and No. 2 syringes is controlled by a micro-injection pump. The flow rate of the No. 1 syringe solution is 0.5ml / min, and the flow rate of the No. 2 syringe solution is 1ml / min. The No. 1 and No. 2 syringes are connected by a tee. One end is connected to the Teflon tubing in the oil bath of the heating unit. The light yellow solution and dodecane pass through the tee of the continuous flow reactor at the same time to form a segment flow, and the liquid part separated by dodecane rolls forward in the small diameter reaction channel of the continuous flow reactor and enters the 122 Reaction in an oil bath at ℃, PdCl 2 Restored by ethylene glycol, the light yellow solution gradually turns gray, and palladium crystals nucleate and grow. The react...
Embodiment 2
[0033] Pipette 0.5ml PdCl 2 solution, add 19.5ml of ethylene glycol, mix evenly to form a light yellow solution, and put it into No. 1 syringe; put dodecane into No. 2 syringe as the carrier phase. The flow rate of the solution in the No. 1 and No. 2 syringes is controlled by a micro-injection pump, the flow rate of the No. 1 syringe solution is 0.7 ml / min, and the flow rate of the No. 2 syringe solution is 1.5 ml / min. The No. 1 and No. 2 syringes are connected by a tee, and the other end is connected with the polytetrafluoroethylene tube in the oil bath of the heating unit. The light yellow solution and dodecane pass through the tee of the continuous flow reactor at the same time to form a segment flow, and the liquid part separated by dodecane rolls forward in the small diameter reaction channel of the continuous flow reactor and enters the 123 Reaction in an oil bath at ℃, PdCl 2 Restored by ethylene glycol, the light yellow solution gradually turns gray, and palladium cr...
Embodiment 3
[0036] Pipette 0.5ml PdCl 2 solution, add 19.5ml of ethylene glycol, mix evenly to form a light yellow solution, and put it into No. 1 syringe; put dodecane into No. 2 syringe as the carrier phase. The flow rate of the solution in No. 1 and No. 2 syringes is controlled by a micro-injection pump, the flow rate of the solution in No. 1 syringe is 1 ml / min, and the flow rate of the solution in No. 2 syringe is 2 ml / min. The No. 1 and No. 2 syringes are connected by a tee, and the other end is connected with the polytetrafluoroethylene tube in the oil bath of the heating unit. The light yellow solution and dodecane pass through the tee of the continuous flow reactor at the same time to form a segment flow, and the liquid part separated by dodecane rolls forward in the small diameter reaction channel of the continuous flow reactor and enters the 125 Reaction in an oil bath at ℃, PdCl 2Restored by ethylene glycol, the light yellow solution gradually turns gray, and palladium cryst...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


